The invention is directed to purified and isolated novel human IL-1
epsilon polypeptides, the nucleic acids encoding such polypeptides,
processes for production of recombinant forms of such polypeptides,
antibodies generated against these polypeptides, fragmented peptides
derived from these polypeptides, the use of such polypeptides and
fragmented peptides in cellular and immune reactions and as molecular
weight markers, the use of such polypeptides and fragmented peptides as
controls for peptide fragmentation, and kits comprising these reagents.
